Patents by Inventor Jieyu LIU

Jieyu LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220278669
    Abstract: The disclosure discloses a two-dimensional high-performance resonator, which is specifically an ultra-high-frequency resonator structure capable of improving an electromechanical coupling coefficient of the resonator. The resonator includes a piezoelectric layer, where an electrode layer is distributed on the upper surface of the piezoelectric layer, the electrode layer includes a plurality of electrodes arranged in a horizontal direction with a distance therebetween greater than four wavelengths, and a bridge structure is arranged on an upper portion of the electrode layer. The resonator structure can effectively improve the resonance frequency and the electromechanical coupling coefficient of the resonator, and can meet the requirements of the 5G market, and the quality factor is greatly improved.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 1, 2022
    Inventors: Chengliang SUN, Jieyu LIU, Jie ZHOU, Xin TONG, Chao GAO, Yang ZOU
  • Publication number: 20220064665
    Abstract: Aspects of the present disclosure relate to genetically modified plants comprising NODULE INCEPTION (NIN) and NIN-LIKE PROTEIN (NLP) that have been genetically altered to be responsive to cytokinin so that the NIN or NLP protein can induce root nodulation upon appropriate signaling.
    Type: Application
    Filed: December 5, 2019
    Publication date: March 3, 2022
    Applicant: Wageningen Universiteit
    Inventors: Rene GEURTS, Jieyu LIU, Luuk RUTTEN, Olga KULIKOVA, Ton BISSELING
  • Publication number: 20220017505
    Abstract: Provided by the present disclosure are an amino quinazolinone and amino isoquinolone derivatives. It is verified by numerous experiments that the compounds provided by the present disclosure have good inhibiting effects on PI3K? and PI3K?, most of the compounds have prominent inhibiting effect on PI3K?, and show strong growth inhibiting effect on PIK3CA mutant tumor cells such as human breast cancer cell strain (MCF7). Therefore, the amino quinazolinone and amino isoquinolone derivatives according to the present disclosure can be applied in the preparation of anti-tumor and anti-inflammatory medicines, and can be used as PI3K? inhibitors in the preparation of medicines for treatment of human or animal cell proliferation related tumors, the medicines comprising the derivatives any one or more of pharmaceutically acceptable salts and solvates thereof as well as pharmaceutically acceptable carriers.
    Type: Application
    Filed: June 25, 2021
    Publication date: January 20, 2022
    Inventors: Rong SHENG, Jia LI, Dongyan GU, Yubo ZHOU, Jun WEI, Mengmeng ZHANG, Yongzhou HU, Kaixiang ZHANG, Jieyu LIU, Weijuan KAN